BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,012,820 | -26.6% | 3,106,000 | -22.4% | 0.00% | -33.3% |
| Q1 2023 | $4,103,920 | -67.0% | 4,000,000 | -65.9% | 0.01% | -68.4% |
| Q4 2022 | $12,454,356 | -100.0% | 11,735,000 | -8.0% | 0.02% | -59.6% |
| Q3 2022 | $29,471,181,000 | +120.6% | 12,760,835 | -5.4% | 0.05% | +123.8% |
| Q2 2022 | $13,360,050,000 | +91.0% | 13,495,000 | +92.8% | 0.02% | +133.3% |
| Q1 2022 | $6,996,500,000 | -10.3% | 7,000,000 | -6.2% | 0.01% | -18.2% |
| Q4 2021 | $7,799,130,000 | +119.3% | 7,459,000 | +114.6% | 0.01% | +120.0% |
| Q3 2021 | $3,555,585,000 | +46.2% | 3,475,000 | +48.1% | 0.01% | +66.7% |
| Q2 2021 | $2,432,196,000 | -63.7% | 2,347,000 | -64.6% | 0.00% | -70.0% |
| Q1 2021 | $6,706,873,000 | +444.9% | 6,628,000 | +477.9% | 0.01% | +400.0% |
| Q4 2020 | $1,230,834,000 | -75.1% | 1,147,000 | -75.6% | 0.00% | -71.4% |
| Q3 2020 | $4,938,241,000 | +130.1% | 4,706,000 | +129.8% | 0.01% | +75.0% |
| Q1 2020 | $2,146,160,000 | +267.9% | 2,048,000 | +264.4% | 0.00% | +300.0% |
| Q2 2019 | $583,429,000 | -73.9% | 562,000 | -76.4% | 0.00% | -75.0% |
| Q1 2018 | $2,234,225,000 | -5.8% | 2,380,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,371,075,000 | – | 2,380,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,298,000 | $15,340,000 | 1.64% |
| ZAZOVE ASSOCIATES LLC | 25,540,000 | $24,103,000 | 1.55% |
| PIER 88 INVESTMENT PARTNERS LLC | 3,030,000 | $2,844,000 | 1.36% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,184,000 | 1.12% |
| Sonora Investment Management, LLC | 7,100,000 | $6,681,214,000 | 1.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 43,256,000 | $40,793,000 | 0.80% |
| Opera Trading Capital | 10,000,000 | $9,370,000 | 0.72% |
| AQR Arbitrage LLC | 52,575,000 | $49,486,000 | 0.57% |
| Neuberger Berman Group LLC | 5,000,000 | $469,375,000 | 0.54% |
| CQS Cayman LP | 12,000,000 | $11,322,000 | 0.52% |